Haemonetics Corporation Stock News

Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Stryker (SYK). But which of these two stocks presents investors with the better v

Haemonetics (HAE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Haemonetics (HAE) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, HAE broke through the 20-day moving average, which suggests a shor

Haemonetics (HAE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

BOSTON , July 10, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2024 financial results at 6:00 am ET on Tuesday, Augu

Investors interested in stocks from the Medical - Products sector have probably already heard of VAREX IMAGING (VREX) and Haemonetics (HAE). But which of these two companies is the best option for tho

Haemonetics (HAE) receives FDA clearance for the advancements made to the NexSys PCS plasma collection system.

Investors interested in Medical - Products stocks are likely familiar with VAREX IMAGING (VREX) and Haemonetics (HAE). But which of these two stocks offers value investors a better bang for their buck

Haemonetics (HAE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Within Haemonetics (HAE) Vascular Closure, growth is led by the opening of new accounts and increasing penetration to gain share in the top U.S. EP hospitals.

Investors are optimistic about Haemonetics (HAE), led by the impressive performance of Plasma and Hospital businesses.

The mean of analysts' price targets for Haemonetics (HAE) points to a 27.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analy

HDELY, WIRE, HAE, GWW and MUSA have been added to the Zacks Rank #1 (Strong Buy) List on May 26, 2023.

Investors with an interest in Medical - Products stocks have likely encountered both Haemonetics (HAE) and Insulet (PODD). But which of these two stocks presents investors with the better value opport

Haemonetics Corporation is showing signs of operational momentum again post-pandemic. After a painful 2021, amidst fears of customer losses, Haemonetics Corporation shares and the company have shown a